Atlas Venture - We build breakthrough biotechnology companies.

Creating and building breakthrough biotechs for over 30 years

Partnering with the world's best life science entrepreneurs

Translating groundbreaking science into life-changing medicines

Scroll to explore

Judo Bio debuts with $100M and a plan to take RNA drugs to the kidney

With $115M more, Triveni accelerates immune drug work

Ron Renaud’s new obesity biotech, Kailera, has $400M to go straight to Phase 3

Thirty years at the leading-edge of medical innovation and we’re just getting started.